JP2021530551A5 - - Google Patents
Info
- Publication number
- JP2021530551A5 JP2021530551A5 JP2021503813A JP2021503813A JP2021530551A5 JP 2021530551 A5 JP2021530551 A5 JP 2021530551A5 JP 2021503813 A JP2021503813 A JP 2021503813A JP 2021503813 A JP2021503813 A JP 2021503813A JP 2021530551 A5 JP2021530551 A5 JP 2021530551A5
- Authority
- JP
- Japan
- Prior art keywords
- administration
- pharmaceutical composition
- composition according
- agents
- excipient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024154560A JP2024170583A (ja) | 2018-07-24 | 2024-09-09 | 超高速凍結による表面改質された治療活性粒子の組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862702674P | 2018-07-24 | 2018-07-24 | |
| US62/702,674 | 2018-07-24 | ||
| PCT/US2019/043202 WO2020023614A1 (en) | 2018-07-24 | 2019-07-24 | Compositions of surface-modified therapeutically active particles by ultra-rapid freezing |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024154560A Division JP2024170583A (ja) | 2018-07-24 | 2024-09-09 | 超高速凍結による表面改質された治療活性粒子の組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021530551A JP2021530551A (ja) | 2021-11-11 |
| JP2021530551A5 true JP2021530551A5 (https=) | 2022-08-01 |
| JP7611813B2 JP7611813B2 (ja) | 2025-01-10 |
Family
ID=69181152
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021503813A Active JP7611813B2 (ja) | 2018-07-24 | 2019-07-24 | 超高速凍結による表面改質された治療活性粒子の組成物 |
| JP2024154560A Pending JP2024170583A (ja) | 2018-07-24 | 2024-09-09 | 超高速凍結による表面改質された治療活性粒子の組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024154560A Pending JP2024170583A (ja) | 2018-07-24 | 2024-09-09 | 超高速凍結による表面改質された治療活性粒子の組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210338671A1 (https=) |
| EP (1) | EP3827260A4 (https=) |
| JP (2) | JP7611813B2 (https=) |
| KR (1) | KR20210038583A (https=) |
| CN (1) | CN112673257B (https=) |
| AU (1) | AU2019311086A1 (https=) |
| BR (1) | BR112021001290A2 (https=) |
| CA (1) | CA3106618A1 (https=) |
| EA (1) | EA202190331A1 (https=) |
| IL (1) | IL280342A (https=) |
| MX (1) | MX2021000796A (https=) |
| WO (1) | WO2020023614A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014186754A2 (en) | 2013-05-16 | 2014-11-20 | Board Of Regents The University Of Texas System | Dry solid aluminum adjuvant-containing vaccines and related methods thereof |
| WO2019118393A1 (en) | 2017-12-11 | 2019-06-20 | Board Of Regents, The University Of Texas System | Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration |
| CN113398079B (zh) * | 2020-03-16 | 2024-01-19 | 鲁南制药集团股份有限公司 | 一种注射用氟达拉滨冻干粉 |
| US12594238B2 (en) | 2020-09-03 | 2026-04-07 | Philip Morris Products S.A. | Low hygroscopicity active powder compositions |
| BR112023003114A2 (pt) * | 2020-09-03 | 2023-04-04 | Philip Morris Products Sa | Composições em pó ativas de baixa higroscopicidade liofilizadas |
| US11793808B2 (en) | 2021-02-22 | 2023-10-24 | Mannkind Corp. | Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them |
| CA3211799A1 (en) * | 2021-03-12 | 2022-09-15 | Robert O. Williams Iii | Methods to prepare dry powders using suspension based thin film freezing |
| US12015755B2 (en) | 2021-03-25 | 2024-06-18 | Korea Advanced Institute Of Science And Technology | Real-time omnidirectional stereo matching method using multi-view fisheye lenses and system thereof |
| CN113484469B (zh) * | 2021-06-30 | 2022-11-18 | 中国科学院青海盐湖研究所 | 水合盐体系相变储能材料纳米尺度相分离的原位表征方法 |
| CN116440084A (zh) * | 2022-01-07 | 2023-07-18 | 浙江萃泽医药科技有限公司 | 一种可吸入的药物粉末制剂及其制备方法 |
| AU2023366929A1 (en) | 2022-10-25 | 2025-05-08 | Veradermics, Incorporated | Compositions and methods of use for modified release minoxidil |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08310969A (ja) * | 1995-05-22 | 1996-11-26 | Lion Corp | 固形薬品組成物及びその製造方法 |
| US7521068B2 (en) * | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
| CN1750811A (zh) * | 2001-10-19 | 2006-03-22 | 巴克斯特国际公司 | 在冷冻水基质中包括颗粒的稳定组合物 |
| GB0321607D0 (en) * | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
| WO2006026502A1 (en) * | 2004-08-27 | 2006-03-09 | The Dow Chemical Company | Enhanced delivery of drug compositions to treat life threatening infections |
| WO2007011396A2 (en) | 2004-10-29 | 2007-01-25 | President And Fellows Of Harvard College | Particles for treatment of pulmonary infection |
| US8361439B1 (en) * | 2005-01-04 | 2013-01-29 | Gp Medical, Inc. | Pharmaceutical composition of nanoparticles |
| EP1954246A4 (en) | 2005-11-11 | 2012-01-18 | Biolab Sanus Farmaceutica Ltda | SOLID PHARMACEUTICAL COMPOSITION WITH AGGLOMERATE NANOTEILES AND MANUFACTURING METHOD THEREFOR |
| WO2011046842A1 (en) * | 2009-10-12 | 2011-04-21 | The Regents Of The University Of California | Targeted nanoclusters and methods of their use |
| EP2720680B1 (en) * | 2011-06-17 | 2020-02-12 | Berg LLC | Inhalable pharmaceutical compositions |
| WO2013132457A2 (en) * | 2012-03-07 | 2013-09-12 | National Institute Of Pharmaceutical Education And Research (Niper) | Nanocrystalline solid dispersion compositions and process of preparation thereof |
| JP6940416B2 (ja) | 2015-05-01 | 2021-09-29 | ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System | 多剤脆性マトリックス組成物 |
-
2019
- 2019-07-24 CN CN201980055623.XA patent/CN112673257B/zh active Active
- 2019-07-24 JP JP2021503813A patent/JP7611813B2/ja active Active
- 2019-07-24 WO PCT/US2019/043202 patent/WO2020023614A1/en not_active Ceased
- 2019-07-24 MX MX2021000796A patent/MX2021000796A/es unknown
- 2019-07-24 KR KR1020217005060A patent/KR20210038583A/ko not_active Ceased
- 2019-07-24 EP EP19840589.6A patent/EP3827260A4/en active Pending
- 2019-07-24 CA CA3106618A patent/CA3106618A1/en active Pending
- 2019-07-24 AU AU2019311086A patent/AU2019311086A1/en active Pending
- 2019-07-24 EA EA202190331A patent/EA202190331A1/ru unknown
- 2019-07-24 US US17/262,313 patent/US20210338671A1/en active Pending
- 2019-07-24 BR BR112021001290-7A patent/BR112021001290A2/pt unknown
-
2021
- 2021-01-21 IL IL280342A patent/IL280342A/en unknown
-
2024
- 2024-09-09 JP JP2024154560A patent/JP2024170583A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021530551A5 (https=) | ||
| Onugwu et al. | Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases | |
| US9017718B2 (en) | Dual and single layer dosage forms | |
| Hooda et al. | A review on oral mucosal drug delivery system | |
| Sharma et al. | Recent developments in nanoparticles for the treatment of diabetes | |
| US20150246002A1 (en) | Abuse-resistant mucoadhesive devices for delivery of buprenorphine | |
| US20210121414A1 (en) | Method for producing a pharmaceutical composition of polymeric nanoparticles for treating neuropathic pain caused by peripheral nerve compression | |
| RU2751508C2 (ru) | Оромукозные нановолоконные носители для терапевтического лечения | |
| JP2024071397A5 (https=) | ||
| JP2024507394A5 (https=) | ||
| WO2018072709A1 (zh) | 医药微丸的干粉包衣组合物 | |
| Lu et al. | Distribution of α-asarone in brain following three different routes of administration in rats | |
| JP2014516045A (ja) | 肺に投与するための安定化剤でコーティングされた生体適合性ナノおよびマイクロ粒子 | |
| JP2018533579A5 (https=) | ||
| JP2023553976A5 (https=) | ||
| US20200222412A1 (en) | Methods and compositions for treating pulmonary hypertension | |
| Mirmeera et al. | Solid lipid nanoparticles of rebamipide: formulation, characterization and in vivo pharmacokinetic evaluation | |
| AU2022209699A1 (en) | Intranasal formulations and delivery of somatostatin mimetics and uses thereof | |
| WO2023087345A1 (zh) | 一种用于治疗肺动脉高压的曲前列尼尔气溶胶吸入剂的雾化方法 | |
| JP2018534244A5 (https=) | ||
| Chang et al. | Nasal drug delivery | |
| US20240108573A1 (en) | Nanolipid carrier based formulation for brain delivery through intranasal route and its preparation process | |
| Chugh et al. | Intranasal drug delivery: a novel approach | |
| Paczkowska-Walendowska et al. | Mucoadhesive chitosan-based drug carriers for local application | |
| CN115569115A (zh) | 一种同时包载全氟化碳和二甲双胍的脂质纳米制剂及其制备方法与应用 |